Bifunctional PAMAM Dendrimer Conjugates of Folic Acid and Methotrexate with Defined Ratio

2012 ◽  
Vol 13 (4) ◽  
pp. 982-991 ◽  
Author(s):  
Hong Zong ◽  
Thommey P. Thomas ◽  
Kyung-Hoon Lee ◽  
Ankur M. Desai ◽  
Ming-hsin Li ◽  
...  
2015 ◽  
Vol 2015 (9) ◽  
pp. 1505-1510 ◽  
Author(s):  
Wanning Hu ◽  
Jan Hoyer ◽  
Ines Neundorf ◽  
Preshendren Govender ◽  
Gregory S. Smith ◽  
...  

Polymers ◽  
2019 ◽  
Vol 11 (9) ◽  
pp. 1422 ◽  
Author(s):  
Marcinkowska ◽  
Stanczyk ◽  
Janaszewska ◽  
Gajek ◽  
Ksiezak ◽  
...  

Taxanes are considered fundamental drugs in the treatment of breast cancer, but despite the similarities, docetaxel (doc) and paclitaxel (ptx) work differently. For this reason, it is interesting to identify mechanisms of antitumor activity of PAMAM dendrimer conjugates that carry docetaxel or paclitaxel and monoclonal antibody trastuzumab, specifically targeted to cells which overexpressed HER-2. For this purpose, the impact on the level of reactive oxygen species, the mitochondrial membrane potential, cell cycle distribution and the activity of caspases-3/7, -8 and -9 of PAMAM-doc-trastuzumab and PAMAM-ptx-trastuzumab conjugates was determined and compared with free docetaxel and paclitaxel toward HER-2-positive (SKBR-3) and negative (MCF-7) human breast cancer cell lines. Moreover, apoptosis and necrosis were studied using flow cytometry and confocal microscopy, respectively. Our studies show the complexity of the potential mechanism of cytotoxic action of PAMAM-drug-trastuzumab conjugates that should be sought as a resultant of oxidative stress, mitochondrial activation of the caspase cascade and the HER-2 receptor blockade.


2013 ◽  
Vol 10 (2) ◽  
pp. 606-618 ◽  
Author(s):  
Alexandra Vetter ◽  
Kulpreet S. Virdi ◽  
Sigrid Espenlaub ◽  
Wolfgang Rödl ◽  
Ernst Wagner ◽  
...  

Sensors ◽  
2009 ◽  
Vol 9 (8) ◽  
pp. 6346-6361 ◽  
Author(s):  
Hidetoshi Arima ◽  
Keiichi Motoyama

2010 ◽  
Vol 21 (2) ◽  
pp. 372-384 ◽  
Author(s):  
Dilip K. Tosh ◽  
Lena S. Yoo ◽  
Moshe Chinn ◽  
Kunlun Hong ◽  
S. Michael Kilbey ◽  
...  

2016 ◽  
Vol 68 (8) ◽  
pp. 1010-1020 ◽  
Author(s):  
Burçin Yavuz ◽  
Sibel Bozdağ Pehlivan ◽  
Burcu Sümer Bolu ◽  
Rana Nomak Sanyal ◽  
İmran Vural ◽  
...  

2008 ◽  
Vol 2008 ◽  
pp. 1-7 ◽  
Author(s):  
Chevelle A. Cason ◽  
Stuart A. Oehrle ◽  
Thomas A. Fabré ◽  
Craig D. Girten ◽  
Keith A. Walters ◽  
...  

Ultra performance liquid chromatography (UPLC) analysis was utilized for the first time as a methodology for monitoring poly(amidoamine) (PAMAM) dendrimer surface transformations and product quality. Results were compared to high-performance liquid chromatography (HPLC) and were found to provide a vastly improved analytical method for the characterization of dendrimer polydispersity and variance in a typical surface modification. The application of UPLC increased the average number of theoretical plates by a factor of 7 and reduced retention times of analytes by 36%, while improving the resolution capability to discriminate surface variances in dendrimers. The new UPLC procedures were used to monitor surface modification of [core: ethylenediamine]; (G = 4);dendri-poly(amidoamine)-(NH2)64(i.e., [EDA]; (G4);dendri-PAMAM-(NH2)64) to produce biotinylated dendrimer conjugates. The enhanced sensitivity and efficiency of the UPLC analyses allowed resolution of biotin substituent levels and a better characterization of the targeted dendrimer conjugates compared to traditional HPLC methodology.


Sign in / Sign up

Export Citation Format

Share Document